Effect of long acting somatostatin-analogue, SMS 201995, on gut hormone secretion in normal subjects
Authors:
- 1 June 1985
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 41 (6) , 738-740
Abstract
SMS 201 995 is a new long acting analogue of somatostatin. We have investigated its effect on basal and meal stimulated secretion of gut hormones and have shown that after a single s. c. injection of 50 μg it lowers significantly the basal plasma levels of pancreatic polypeptide, secretin, motilin, pancreatic glucagon and insulin, it also effectively suppresses the postprandial release of pancreatic polypeptide, gastrin, secretin, gastric inhibitory peptide, pancreatic glucagon and insulin. Except for the usual brief discomfort of an injection, no symptoms or untoward effects were observed.Keywords
This publication has 14 references indexed in Scilit:
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Somatostatin - A Regulatory Modulator Connecting Nutrient Entry and MetabolismHormone and Metabolic Research, 1980
- SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUEThe Lancet, 1979
- The Carcinoid FlushNew England Journal of Medicine, 1978
- Somatostatin: Analogs with Selected Biological ActivitiesScience, 1977
- D-Trp8-somatostatin: An analog of somatostatin more potent than the native moleculeBiochemical and Biophysical Research Communications, 1975
- INHIBITION OF GASTRIN AND GASTRIC-ACID SECRETION BY GROWTH-HORMONE RELEASE-INHIBITING HORMONEThe Lancet, 1974
- Effects of Somatostatin on the Secretion of Thyrotropin and ProlactinEndocrinology, 1974
- Inhibition by Somatostatin on the Release of TSH Induced in Man by Thyrotropin-Releasing FactorThe Journal of Clinical Endocrinology & Metabolism, 1974
- Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth HormoneScience, 1973